GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Tremendous amount of RNA sequencing data have been produced by large consortium projects such as TCGA and GTEx, creating new opportunities for data mining and deeper understanding of gene functions. While certain existing web servers are valuable and widely used, many expression analysis functions needed by experimental biologists are still not adequately addressed by these tools. We introduce GEPIA (Gene Expression Profiling Interactive Analysis), a web-based tool to deliver fast and customizable functionalities based on TCGA and GTEx data. GEPIA provides key interactive and customizable functions including differential expression analysis, profiling plotting, correlation analysis, patient survival analysis, similar gene detection and dimensionality reduction analysis. The comprehensive expression analyses with simple clicking through GEPIA greatly facilitate data mining in wide research areas, scientific discussion and the therapeutic discovery process. GEPIA fills in the gap between cancer genomics big data and the delivery of integrated information to end users, thus helping unleash the value of the current data resources. GEPIA is available at http://gepia.cancer-pku.cn/.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A comprehensive analysis of the correlation between expression levels of these genes and ENO1 in liver cancer (Figure 1B; Tang et al., 2017) as well as the association between high or low expression level of these genes and hepatocellular carcinoma (HCC) prognosis (Figure 1C; Menyhart et al., 2018) revealed that GAPDH, BACE2, and TRIM36 were the top 3 genes (Figure 1D; Supplementary Figure S1A).”
From ENO1–BACE2-mediated LDLR cleavage promotes liver cancer progression by remodelling cholesterol metabolism (2025) · cites this paper as Tang et al., 2017
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Our analysis of genomic alterations in glioblastoma according to data in the Cancer Genome Atlas (TCGA) identified the q13–15 region of chromosome 12 as one of the regions that most often rearranged in the disease (Fig. 1A and B)5, 6, 7.”
From Rational drug design, synthesis, and biological evaluation of novel chiral tetrahydronaphthalene-fused spirooxindole as MDM2-CDK4 dual inhibitor against glioblastoma (2020) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
RNA-Seq: a revolutionary tool for transcriptomics
Wang, Z., Gerstein, M., & Snyder, M. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2484 · Cited by 13,174 · cited 1×
“High-throughput RNA sequencing (RNA-Seq) has emerged as a powerful method for transcriptomic analysis (1), widely used for understanding gene functions and biological patterns, finding candidate drug targets and identifying biomarkers for disease classification and diagnosis (2).”
MethodThe cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092 · cited 9×
“To solve the imbalance between the tumor and normal data which can cause inefficiency in various differential analyses, we download the TCGA and GTEx gene expression data that are re-computed from raw RNA-Seq data by the UCSC Xena project based on a uniform pipeline (Figure 1).”
BackgroundInfluentialThe Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
The GTEx Consortium, Ardlie, K. G., Deluca, D. S., Segrè, A. V., Sullivan, T. J., Young, T. R., Gelfand, E. T., Trowbridge, C. A., Maller, J. B., Tukiainen, T., et al. (2015) · Science · doi:10.1126/science.1262110 · Cited by 5,062
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Welsh, J. B., Sapinoso, L. M., Su, A. I., Kern, S. G., Wang‐Rodriguez, J., Moskaluk, C. A., Frierson, H. F., & Hampton, G. M. (2001) · PubMed · Cited by 856
Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer
Plitas, G., Konopacki, C., Wu, K., Bos, P. D., Morrow, M., Putintseva, E. V., Chudakov, D. M., & Rudensky, A. Y. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.032 · Cited by 695 · cited 1×
“Survival analysis based on gene expression levels is also widely used for evaluating the clinical importance of a given gene (11).”
Welsh, J. B., Zarrinkar, P. P., Sapinoso, L. M., Kern, S. G., Behling, C. A., Monk, B. J., Lockhart, D. J., Burger, R. A., & Hampton, G. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1176 · Cited by 654
Revisiting Global Gene Expression Analysis
Lovén, J., Orlando, D. A., Sigova, A. A., Lin, C. Y., Rahl, P. B., Burge, C. B., Levens, D. L., Lee, T. I., & Young, R. A. (2012) · Cell · doi:10.1016/j.cell.2012.10.012 · Cited by 616 · cited 1×
“High-throughput RNA sequencing (RNA-Seq) has emerged as a powerful method for transcriptomic analysis (1), widely used for understanding gene functions and biological patterns, finding candidate drug targets and identifying biomarkers for disease classification and diagnosis (2).”
MethodPetryszak, R., Keays, M., Tang, Y. A., Fonseca, N. A., Barrera, E., Burdett, T., Füllgrabe, A., Fuentes, A. M.-P., Jupp, S., Koskinen, S., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1045 · Cited by 530 · cited 5×
“org/), HPA (12) and Expression Atlas (13) have provided many useful visualization and analysis tools for gene expression analysis.”
MethodInfluential
Cited by
Items 101–200 of 1,028
DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation
Cui, H., Wang, Q., Lei, Z., Feng, M., Zhao, Z., Wang, Y., & Wei, G. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1358-x · Cited by 150
The lysine‐specific methyltransferase KMT2C/MLL3 regulates DNA repair components in cancer
Rampias, T. N., Karagiannis, D., Avgeris, M., Polyzos, A., Kokkalis, A., Kanaki, Z., Kousidou, E., Tzetis, M., Kanavakis, E., STRAVODIMOS, K. G., et al. (2019) · EMBO Reports · doi:10.15252/embr.201846821 · Cited by 150
RETRACTED: Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Breast Cancer
Sun, C., Li, S., Hu, W., Zhang, J., Zhou, Q. Y., Liu, C., Li, L., Songyang, Y., Zhang, F., Chen, Z., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.03.019 · Cited by 140
“GEPIA provides customizable functions such as tumor/normal differential expression analysis, profiling according to cancer types or pathological stages, patient survival analysis, similar gene detection, correlation analysis, and dimensionality reduction analysis.(43)”
MethodRetractedTian, S., Zhang, J., Yuan, S., Wang, Q., Lv, C., Wang, J., Fang, J., Fu, L., Yang, J., Zu, X., et al. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad027 · Cited by 148
Multiomics Evaluation of Gastrointestinal and Other Clinical Characteristics of COVID-19
Du, M., Cai, G., Chen, F., Christiani, D. C., Zhang, Z., & Wang, M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.03.045 · Cited by 134
Self-citationAzevedo, R., Shoshan, E., Whang, S., Markel, G., Jaiswal, A. R., Liu, A. J., Curran, M. A., Travassos, L. R., & Bar‐Eli, M. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1846915 · Cited by 173
“cn/#survival) to assess MIF expression levels in several cancer types, as well the overall survival analyses based on the cancer type and cancer subtype to determine the significant prognostic impact of MIF expression level.(22) Also, we interrogated the Tumor IMmune Estimation Resource (TIMER)(23) (https://cistrome.”
MethodPeng, L., Chen, Z., Chen, Y., Wang, X., & Tang, N. (2019) · Cancer Medicine · doi:10.1002/cam4.2583 · Cited by 146
Gong, P., Shao, Y.-C., Yang, Y. T., Song, W., He, X., Zeng, Y., Huang, S., Wei, L., & Zhang, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.578963 · Cited by 144
“(A, B) The correlation between APC and METTL14, ZC3H13 mRNA expression determined using GEPIA.”
InfluentialB7H3 As a Promoter of Metastasis and Promising Therapeutic Target
Dong, P., Xiong, Y., Yue, J., Hanley, S. J. B., & Watari, H. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00264 · Cited by 139
“1 In agreement with previous reports, RNA sequencing analysis of mRNA expression from the GEPIA online database (46) revealed that B7H3 expression levels tend to be higher in breast, ovarian, endometrial, lung, liver, and gastric cancer tissues compared to corresponding normal tissues (Figure 1A).”
ResultTargeting HNRNPU to overcome cisplatin resistance in bladder cancer
Shi, Z., Hao, L., Han, X., Wu, Z., Pang, K., Dong, Y., Qin, J., Wang, G., Zhang, X., Xia, T., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01517-9 · Cited by 139
“UALCAN, CbioPortal, and GEPIA were used for pancancer analysis and expression analysis of the HNRNPU gene [19, 20].”
MethodZou, Y., Ruan, S., Jin, L., Chen, Z., Han, H., Zhang, Y., Jian, Z., Lin, Y., Shi, N., & Jin, H. (2020) · Medical Science Monitor · doi:10.12659/msm.925289 · Cited by 149
“cn/) is an online database that contains expression data based on 9736 tumors and 8587 normal tissues from GTEx and TCGA [20].”
MethodInfluentialScreening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis
Zhou, Z., Li, Y., Hao, H., Wang, Y., Zhou, Z., Wang, Z., & Chu, X. (2019) · Cell Transplantation · doi:10.1177/0963689719893950 · Cited by 142
An update on the status of HSP90 inhibitors in cancer clinical trials
Rastogi, S., Joshi, A., Sato, N., Lee, S., Lee, M.-J., Trepel, J. B., & Neckers, L. (2024) · Cell Stress and Chaperones · doi:10.1016/j.cstres.2024.05.005 · Cited by 139
Overexpression of kinesin superfamily members as prognostic biomarkers of breast cancer
Li, T., Zeng, H., Shan, Z., Ye, R.-Y., Cheang, T., Zhang, Y., Lu, S.-H., Zhang, Q., Shao, N., & Lin, Y. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01191-1 · Cited by 146
SPP1 promotes ovarian cancer progression via Integrin β1/FAK/Akt signaling pathway
zeng, B., Zhou, M., Wu, H., & Xiong, Z.-A. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s154215 · Cited by 132
“9E–07; Figure 3C).(25) Previous studies revealed that ITGB1 is involved in the development of ovarian cancer via FAK/AKT pathway.”
Kynurenine emerges from the shadows – Current knowledge on its fate and function
Marszałek‐Grabska, M., Walczak, K., Gaweł, K., Wicha-Komsta, K., Wnorowska, S., Wnorowski, A., & Turski, W. A. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107845 · Cited by 136
Perelroizen, R., Philosof, B., Budick-Harmelin, N., Chernobylsky, T., Ron, A., Katzir, R., Shimon, D., Tessler, A., Adir, O., Gaoni-Yogev, A., et al. (2022) · Brain · doi:10.1093/brain/awac222 · Cited by 135
Kindlin-2 links mechano-environment to proline synthesis and tumor growth
Guo, L., Cui, C., Zhang, K., Wang, J., Wang, Y., Lu, Y., Chen, K., Yuan, J., Xiao, G., Tang, B. H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08772-3 · Cited by 136
Li, B., Shen, W., Peng, H., Li, Y., Chen, F., Zheng, L., Xu, J., & Jia, L. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s195703 · Cited by 142
“GEPIA is a web server used to analyze cancer and normal gene expression profiling and interaction.(21) The boxplot was performed to visualize the relationship.”
MethodSOAT1 promotes mevalonate pathway dependency in pancreatic cancer
Oni, T. E., Biffi, G., Baker, L. A., Hao, Y., Tonelli, C., Somerville, T. D. D., Deschênes, A., Belleau, P., Hwang, C.-I., Sánchez-Rivera, F. J., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20192389 · Cited by 122
“…of The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression datasets with the Gene Expression Profiling Interactive Analysis (GEPIA) tool (Tang et al., 2017) confirmed the up-regulation of SOAT1, SREBF2, and SREBP2 target genes (LDLR and HMGCR) in human PDAC compared with normal pancreas…”
MethodPan, Z., Xu, T., Bao, L., Hu, X., Jin, T., Chen, J., Chen, J., Qian, Y., Lu, X., li, L., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01658-x · Cited by 136
Wang, Z., Gao, L., Guo, X., Feng, C., Lian, W., Deng, K., & Xing, B. (2019) · Aging · doi:10.18632/aging.102566 · Cited by 159
“The differential expression of the above three genes in tumor and normal tissues was further validated in the Gene Expression Profiling Interactive Analysis (GEPIA) database, which included 163 GBM samples and 207 normal samples, revealing that ITGA3 was significantly upregulated but NRG1 and MAP1LC3A were significant…”
BackgroundZhang, D., Bi, J., Liang, Q., Wang, S., Zhang, L., Han, F., Li, S., Qiu, B., Fan, X., Chen, W., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01066 · Cited by 142
CD206+ tumor-associated macrophages cross-present tumor antigen and drive antitumor immunity
Modak, M., Mattes, A.-K., Reiss, D., Skrońska-Wąsek, W., Langlois, R., Sabarth, N., Konopitzky, R., Ramírez, F., Lehr, K., Mayr, T., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.155022 · Cited by 136
Segal, J. M., Kent, D., Wesche, D. J., Ng, S. S., Serra, M., Oulès, B., Kar, G., Emerton, G., Blackford, S. J. I., Darmanis, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11266-x · Cited by 125
El‐Arabey, A. A., Denizli, M., Kanlikilicer, P., Bayraktar, R., Ivan, C., Rashed, M. H., Kabil, N. N., Özpolat, B., Calin, G. A., Salama, S. A., et al. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109539 · Cited by 132
Integrative Bioinformatics Analysis for Targeting Hub Genes in Hepatocellular Carcinoma Treatment
Gudivada, I. P., & Amajala, K. C. (2024) · Current Genomics · doi:10.2174/0113892029308243240709073945 · Cited by 129
Zhu, Y., Liu, X., Zhao, P., Zhao, H., Gao, W., & Wang, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00025 · Cited by 130
“The correlation between the expression of the VM-related protein EphA2 in GBM tissues and the survival rate was analyzed with the Gene Expression Profiling Interactive Analysis (GEPIA) database (Tang et al., 2017).”
Gu, C.-C., Cai, J., Xu, Z., Zhou, S., Ye, L., Yan, Q., Zhang, Y., Fang, Y., Liu, Y., Tu, C., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1962-x · Cited by 126
Insights into the role of GPX3, a highly efficient plasma antioxidant, in cancer
Nirgude, S., & Choudhary, B. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114365 · Cited by 140
A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer
Gu, P., Chen, X., Xie, R., Xie, W., Huang, L., Dong, W., Han, J., Liu, X., Shen, J., Huang, J., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1037-8 · Cited by 127
“Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.”
MethodInfluentialxCT-Driven Expression of GPX4 Determines Sensitivity of Breast Cancer Cells to Ferroptosis Inducers
Lee, N., Carlisle, A. E., Peppers, A., Park, S. J., Doshi, M. B., Spears, M. E., & Kim, D. (2021) · Antioxidants · doi:10.3390/antiox10020317 · Cited by 135
m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer
Zhao, H., Xu, Y., Xie, Y., Zhang, L., Gao, M., Li, S., & Wang, F. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.650023 · Cited by 136
“Expression Analysis Gepia 21 was used to compare the expression of m6A regulators (Tang et al., 2017).”
MethodHe, S., Cheng, J. Q., Sun, L., Wang, Y., Wang, C., Liu, X., Zhang, Z., Zhao, M., Luo, Y., Tian, L., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0626-6 · Cited by 131
Self-citationZhang, J., Yang, J., Lin, C., Liu, W., Huo, Y., Yang, M., Jiang, S., Sun, Y., & Hua, R. (2020) · Theranostics · doi:10.7150/thno.45124 · Cited by 140
“html) [22], which provides an overview of the TCGA/GTEx data, was used to analyze the expression pattern and prognostic value of ERO1L gene across 33 types of human cancers.”
MethodSu, C., Lv, Y., Lu, W., Yu, Z., Ye, Y., Guo, B., Liu, D., Yan, H., Li, T., Zhang, Q., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.719564 · Cited by 115
Joung, J., Kirchgatterer, P. C., Singh, A., Cho, J. H., Nety, S. P., Larson, R. C., Macrae, R. K., Deasy, R., Tseng, Y., Maus, M. V., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29205-8 · Cited by 128
Luo, Y., Huang, S., Wei, J., Zhou, H., Wang, W., Yang, J., Deng, Q., Wang, H., & Fu, Z. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.752 · Cited by 127
Genome-wide identification and analysis of prognostic features in human cancers
Smith, J. C., & Sheltzer, J. M. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110569 · Cited by 134
Zeng, C., Lin, J., Zhang, K., Ou, H., Shen, K., Liu, Q., Wei, Z., Dong, X., Zeng, X., Zeng, L., et al. (2022) · Cancer Science · doi:10.1111/cas.15531 · Cited by 129
Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells
Chen, Y., Pan, C., Wang, X., Xu, D., Ma, Y., Hu, J., Chen, P., Xiang, Z., Rao, Q., & Han, X. (2021) · Theranostics · doi:10.7150/thno.61178 · Cited by 136
“cn) revealed patients with higher METTL3 mRNA levels exhibited much shorter relapse-free survival rate (Figure 1K) [22]; however, no significant correlation between METTL14, FTO, or ALKBH5 expression and survival rate was observed (Figure 1L-N).”
ResultNan, P., Dong, X. R., Bai, X., Lu, H., Liu, F., Sun, Y., & Zhao, X. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.12.025 · Cited by 125
Ren, L., Yang, Y., Li, W., Zheng, X., Liu, J., Li, S., Yang, H. S., Zhang, Y., Ge, B., Zhang, S., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03641-y · Cited by 124
Ni, M., Liu, X., Wu, J., Zhang, D., Tian, J., Wang, T., Liu, S., Meng, Z., Wang, K., Duan, X., et al. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00469 · Cited by 133
Kao, T., Wu, C.-C., Phan, N. N., Liu, Y.-H., Ta, H. D. K., Anuraga, G., Wu, Y.-F., Lee, K., Chuang, J., & Wang, C. (2021) · Aging · doi:10.18632/aging.203345 · Cited by 130
“Meanwhile, we also assessed the prognostic value of PSMC gene family members for pan-cancer analysis in GEPIA2, which contains RNA sequencing expression data from different types of tumors as well as the normal samples from the TCGA and GTEx projects, including Cholangio carcinoma, Colon adenocarcinoma, Lymphoid Neopl…”
BackgroundA comprehensive bioinformatic analysis of cyclin-dependent kinase 2 (CDK2) in glioma
Liu, H., & Weng, J. (2022) · Gene · doi:10.1016/j.gene.2022.146325 · Cited by 120
GEPIA3: Enhanced drug sensitivity and interaction network analysis for cancer research
Kang, Y.-J., Pan, L., Liu, Y., Rong, Z., Liu, J., & Liu, F. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf423 · Cited by 127
“The original [ 3 ] web server, launched in 2017, provided users with a user-friendly interface to conduct differential gene expression analyses, survival assessments, and gene correlation studies across diverse cancer datasets derived from TCGA and GTEx.”
Treeck, O., Buechler, C., & Ortmann, O. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153750 · Cited by 126
Kynurenic acid and cancer: facts and controversies
Walczak, K., Wnorowski, A., Turski, W. A., & Plech, T. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03332-w · Cited by 122
CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma
Gu, Y., Li, X., Bi, Y., Zheng, Y., Wang, J., Li, X., Huang, Z., Chen, L., Huang, Y., & Huang, Y. (2020) · Aging · doi:10.18632/aging.102656 · Cited by 133
“TIMER database was used to systematically analyze the tumor-infiltrating immune cells (TIICs) in 32 cancer types using more than 10,000 samples from The Cancer Genome Atlas (TCGA) (https://cistrome.shinyapps. io/timer/) database [25].”
BackgroundMethodInfluentialTargeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug
Bi, J., Khan, A. A., Tang, J., Armando, A. M., Wu, S., Zhang, W., Gimple, R. C., Reed, A., Jing, H., Koga, T., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109957 · Cited by 125
“(Tang et al., 2017) was used to analyze the expression of metabolic genes between GBM tumors and normal brains based on TCGA and GTEx RNA-seq data.”
HumCFS: a database of fragile sites in human chromosomes
Kumar, R., Nagpal, G., Kumar, V. D., Usmani, S. S., Agrawal, P., & Raghava, G. P. S. (2019) · BMC Genomics · doi:10.1186/s12864-018-5330-5 · Cited by 122
The role of YWHAZ in cancer: A maze of opportunities and challenges
Gan, Y., Feng, Y., & He, X. (2020) · Journal of Cancer · doi:10.7150/jca.41316 · Cited by 126
“We also conducted Kaplan-Meier survival analysis in Gene Expression Profiling Interactive Analysis (GEPIA) database with larger samples [77], determining that overall survival time was remarkably longer in LIHC (p = 0.”
MethodNelson, J. K., Thin, M. Z., Evan, T., Howell, S. A., Wu, M., Almeida, B., Legrave, N. M., Koenis, D. S., Koifman, G., Sugimoto, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29684-9 · Cited by 126
Li, Y., Li, Q., Yuan, R., Wang, Y., Guo, C., & Wang, L. (2024) · Theranostics · doi:10.7150/thno.92350 · Cited by 123
“The Gene Expression Profiling Interactive Analysis (GEPIA) data source [25] was used to evaluate CYP1A1 , CYP1A2 , and CYP1B1 levels in healthy individuals and CRC patients via the “Expression DIY” page.”
MethodHnRNPR-CCNB1/CENPF axis contributes to gastric cancer proliferation and metastasis
Chen, E., Qin, X., Peng, K., Li, Q., Tang, C. W., Cheng, X., Wei, Y., Yu, S., Gan, L., & Liu, T. (2019) · Aging · doi:10.18632/aging.102254 · Cited by 122
Kosti, A., Araujo, P. R. D., Li, W.-Q., Guardia, G. D. A., Chiou, J., Yi, C., Ray, D., Meliso, F. M., Li, Y.-M., Delambre, T., et al. (2020) · Genome biology · doi:10.1186/s13059-020-02115-y · Cited by 121
Yu, Z., Jiang, X., Qin, L., Deng, H., Wang, J., Ren, W., Li, H., Zhao, L., Liu, H., Yan, H., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01572-w · Cited by 117
Huang, M. X., Dong, W., Xie, R., Wu, J., Su, Q., Li, W., Yao, K., Chen, Y., Zhou, Q., Zhang, Q., et al. (2022) · 癌症:英文版 · doi:10.1002/cac2.12284 · Cited by 123
Nuclear Glycogenolysis Modulates Histone Acetylation in Human Non-Small Cell Lung Cancers
Sun, R. C., Dukhande, V. V., Zhou, Z., Young, L. E. A., Emanuelle, S., Brainson, C. F., & Gentry, M. S. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.014 · Cited by 133
“Kaplan-Meier Survival Analysis—Kaplan-Meier survival analysis was performed based on the method previously published (Tang et al., 2017).”
MethodChinn, I. K., Chan, A. Y. K., Chen, K., Chou, J. S., Dorsey, M. J., Hajjar, J., Jongco, A. M., Keller, M. D., Kobrynski, L. J., Kumánovics, A., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.09.009 · Cited by 123
“Finally, a number of resources have been developed to assist with integrated analysis of protein expression data in tissues, including the GeneCards Human Integrated Protein Expression Database and the Gene Expression Profiling Interactive Analysis web server (Table VI).(91) Evidence for plausibility also comes from e…”
MethodZhao, S., Zhang, Y., Lu, X., Ding, H., Han, B., Song, X., Miao, H., Cui, X., Wei, S., Liu, W., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.64003 · Cited by 119
“high expression of CDC20 will lead to a worse prognosis of HCC patients; while inhibiting CDC20 will increase the radiosensitivity of HCC tumor cells, thus providing a new direction and idea for us to treat HCC [22, 23].”
BackgroundYin, H., Pu, N., Chen, Q., Zhang, J., Zhao, G., Xu, X., Wang, D., Kuang, T., Jin, D., Lou, W., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04293-4 · Cited by 118
“cn/) was used to analyze the gene expression profiling TCGA database [40].”
MethodHeat Shock Proteins and HSF1 in Cancer
Cyran, A. M., & Zhitkovich, A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.860320 · Cited by 117
Identification of core genes and outcome in gastric cancer using bioinformatics analysis
Sun, C., Yuan, Q., Wu, D., Meng, X., & Wang, B. (2017) · Oncotarget · doi:10.18632/oncotarget.20082 · Cited by 117
“com/oncotarget and 8,587 normal samples from the TCGA and the GTEx projects, using a standard processing pipeline [24].”
MethodComplex roles of nicotinamide N-methyltransferase in cancer progression
Wang, W., Yang, C., Wang, T., & Deng, H. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04713-z · Cited by 115
“Further, methionine adenosyltransferase, MAT1A is expressed predominantly in the adult liver but observably decrease in LIHC patients, implying an elevation of methionine levels and a reduction of SAM levels in LIHC cells [57, 109].”
BackgroundResultInfluentialA Comprehensive Bioinformatics Analysis of UBE2C in Cancers
Dastsooz, H., Cereda, M., Donna, D., & Oliviero, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092228 · Cited by 119
mRNAsi Index: Machine Learning in Mining Lung Adenocarcinoma Stem Cell Biomarkers
Zhang, Y., Tseng, J. T.-C., Lien, I.-C., Li, F., Wu, W., & Li, H. (2020) · Genes · doi:10.3390/genes11030257 · Cited by 123
Li, Y., He, Y., Peng, J., Su, Z., Li, Z., Zhang, B., Ma, J., Zhuo, M., Zou, D., Liu, X., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-00134-z · Cited by 113
Zhang, B., Zhang, Z., Li, L., Qin, Y.-R., Liu, H., Jiang, C., Zeng, T.-T., Li, M.-Q., Xie, D., Li, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03716-9 · Cited by 121
Self-citationCCNA2 acts as a novel biomarker in regulating the growth and apoptosis of colorectal cancer
Gan, Y., Li, Y., Li, T., Shu, G., & Yin, G. (2018) · Cancer Management and Research · doi:10.2147/cmar.s176833 · Cited by 112
“Overall, they were all associated with cell growth, cell invasion, cell proliferation, the cell cycle, and microsatellite instability (MSI), all of which play critical roles in the process of tumorigenesis.(36) MSI tumors usually arise because of a genetic defect in the MMR genes which is one of the main DNA-repair sy…”
BackgroundJiang, L., Wang, R., Fang, L., Ge, X., Chen, L., Zhou, M., Zhou, Y., Xiong, W., Hu, Y., Tang, X., et al. (2019) · Theranostics · doi:10.7150/thno.31097 · Cited by 111
“cn/) [22], we found lncRNAs responsible to TGF-β/SMAD3 and overexpression in tissue samples of patients with LUAD.”
BackgroundZheng, L., Xu, M., Xu, J., Wu, K., Fang, Q., Liang, Y., Zhou, S., Cen, D., Ji, L., Han, W., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0399-y · Cited by 106
Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry
Freudenmann, L. K., Marcu, A., & Stevanović, S. (2018) · Immunology · doi:10.1111/imm.12936 · Cited by 109
Yang, H. J., Li, H., Hu, S., & Zhou, Y. (2020) · Aging · doi:10.18632/aging.103100 · Cited by 125
“cn/) [29] and Kaplan-Meier plotter (http://kmplot.”
Immunoglobulin Expression in Cancer Cells and Its Critical Roles in Tumorigenesis
Cui, M., Huang, J., Zhang, S., Liu, Q., Liao, Q., & Qiu, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.613530 · Cited by 124
Zhu, W., Wang, J., Liu, X., Yanbin, X., Zhai, R., Zhang, J., Wang, M., Wang, M., & Liu, L. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05157-1 · Cited by 118
“Assessment of the Kaplan–Meier curves of these six lncRNAs from TCGA using the PrognoScan database and Gene Expression Profiling Interactive Analysis (GEPIA) [30] (Supplementary Fig.”
MethodWu, D., Wen, X., Han, X., Wang, S., Wang, Y., Shen, M., Fan, S., Zhang, Z.-F., Shan, Q., Li, M., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.02.022 · Cited by 107
Self-citationRetractedGuilhamon, P., Chesnelong, C., Kushida, M. M., Nikolić, A., Singhal, D., MacLeod, G. D. A. H., Tonekaboni, S. A. M., Cavalli, F. M. G., Arlidge, C., Rajakulendran, N., et al. (2021) · eLife · doi:10.7554/elife.64090 · Cited by 127
“The expression levels of key transcription factors in tumor and normal samples were analyzed and displayed using GEPIA (Tang et al., 2017).”
MethodThe Global Research of Artificial Intelligence on Prostate Cancer: A 22-Year Bibliometric Analysis
Shen, Z., Wu, H., Chen, Z., Hu, J., Pan, J., Kong, J., & Lin, T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.843735 · Cited by 107
Overexpression of GSDMC is a prognostic factor for predicting a poor outcome in lung adenocarcinoma
Wei, J., Xu, Z., Chen, X., Wang, X., Zeng, S., Qian, L., Yang, X., Ou, C., Lin, W., Gong, Z., et al. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10837 · Cited by 117
Comprehensive Review of Web Servers and Bioinformatics Tools for Cancer Prognosis Analysis
Zheng, H., Zhang, G., Zhang, L., Wang, Q., Li, H., Han, Y., Xie, L., Yan, Z., Li, Y., An, Y., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00068 · Cited by 116
“GEPIA11 GEPIA is an interactive web-based tool for survival analysis based on gene expression, it offer the choice of selecting overall survival (OS) or disease-free survival (DFS) for the analysis (35, 36).”
MethodMETTL6 is a tRNA m 3 C methyltransferase that regulates pluripotency and tumor cell growth
Ignatova, V. V., Kaiser, S., Ho, J., Bing, X., Stolz, P., Tan, Y. X., Lee, C. L., Gay, F. P. H., Lastres, P. R., Gerlini, R., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz4551 · Cited by 111
Pedersen, K. M., Çolak, Y., Bojesen, S. E., & Nordestgaard, B. G. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00963-6 · Cited by 112
Zheng, C., Yu, X., Liang, Y., Zhu, Y., He, Y., Liao, L., Wang, D.-K., Yang, Y., Yin, X., Li, A., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.007 · Cited by 106
YAP/TAZ drives cell proliferation and tumour growth via a polyamine–eIF5A hypusination–LSD1 axis
Li, H., Wu, B.-K., Kanchwala, M., Cai, J., Wang, L., Xing, C., Zheng, Y., & Pan, D. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00848-5 · Cited by 107
Clinical considerations for the design of PROTACs in cancer
Nieto‐Jiménez, C., Morafraile, E. C., Alonso‐Moreno, C., & Ocaña, A. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01535-7 · Cited by 106
“cn/) (last accessed in August 2021) [13], we analyzed the expression (in transcripts per million, TPM) of these targets and ligases in the tumoral tissue of the mentioned five cancer types.”
BackgroundMethodInfluentialZhang, C., Zeng, Y., Guo, X., Shen, H., Zhang, J., Wang, K., Ji, M., & Huang, S. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.923737 · Cited by 117
“For some cancers lacking paracancerous control samples, we integrated the TCGA data and the GTEx data from GEPIA website (Tang et al., 2017) (http://gepia.”
MethodExpression of the inhibitory B7 family molecule VISTA in human colorectal carcinoma tumors
Xie, S., Huang, J., Qiao, Q., Zang, W., Hong, S., Tan, H., Dong, C., Yang, Z., & Ni, L. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2227-8 · Cited by 105
CD73 promotes tumor metastasis by modulating RICS/RhoA signaling and EMT in gastric cancer
Xu, Z., Gu, C.-C., Yao, X., Guo, W., Wang, H., Tian, L., Li, F., Chen, D., Wu, J., Ye, G., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2403-6 · Cited by 113
Shen, T., Li, Y., Zhu, S., Yu, J., Zhang, B., Chen, X., Zhang, Z., Ma, Y., Niu, Y., & Shang, Z. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-1542-z · Cited by 117
Self-citationCai, X., Chen, Y., Man, D., Yang, B., Feng, X., Zhang, D., Chen, J., & Wu, J. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00703-w · Cited by 114
HAT1 Coordinates Histone Production and Acetylation via H4 Promoter Binding
Gruber, J. J., Geller, B., Lipchik, A. M., Chen, J., Salahudeen, A. A., Ram, A. N., Ford, J. M., Kuo, C. J., & Snyder, M. P. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.05.034 · Cited by 100
The Hippo Pathway Effector YAP Promotes Ferroptosis via the E3 Ligase SKP2
Yang, W., Lin, C., Wu, J., Chao, P.-Y., Chen, K., Chen, P., & Chi, J. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0534 · Cited by 106
“Third, we analyzed the expression levels of YAP and SKP2 and found a significant positive correlation (P¼ 1.3e 15) in the breast invasive carcinoma data set byGeneExpression Profiling Interactive Analysis (GEPIA) database (Supplementary Fig.”
MethodInfluentialFascin promotes lung cancer growth and metastasis by enhancing glycolysis and PFKFB3 expression
Lin, S., Li, Y., Wang, D., Huang, C., Marino, D., Bollt, O., Wu, C., Taylor, M. D., Li, W., DeNicola, G. M., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.07.025 · Cited by 108
Zhang, M., Pan, X., Fujiwara, K., Jurcak, N. R., Muth, S. T., Zhou, J., Xiao, Q., Li, A., Che, X., Li, Z., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00769-z · Cited by 106
“cn) analysis methods were used to assess the correlation between the gene expression of integrin αV/β8, GARP, and TGFβ−1 and that of immune markers as well as the estimated immune cells infiltration.(43,44)”
MethodWei, L., Lin, Q., Lu, Y., Li, G., Huang, L., Fu, Z., Chen, R., & Zhou, Q. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03574-2 · Cited by 112
miR-454-3p Is an Exosomal Biomarker and Functions as a Tumor Suppressor in Glioma
Shao, N., Xue, L., Wang, R., Luo, K., Zhi, F., & Lan, Q. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0725 · Cited by 95
“html) (19) as shown in Supplementary Fig.”
Fan, P., Zhao, J., Meng, Z., Wu, H., Wang, B., Wu, H., & Jin, X. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1044-z · Cited by 99
“) [22] was used to analyze the RNA sequencing expression data related to our project based on The Cancer Genome Atlas (TCGA) and the Genotype-Tissue Expression (GTEx) projects.”
Yan, F., Li, J., Milosevic, J., Petroni, R., Liu, S., Shi, Z., Yuan, S., Reynaga, J. M., Qi, Y., Rico, J., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1459 · Cited by 104
Metadata
- Authors
- Tang, Z., Li, C., Kang, B., Gao, G., Li, C., & Zhang, Z.
- Affiliations
- Peking University (CN)
- University of California, Santa Cruz (US)
- Corresponding author
- Tang, Zefang
- Li, Chenwei
- Zhang, Zemin
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-04-12
- Volume
- 45
- Issue
- W1
- Pages
- W98-W102
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC5570223
- OpenAlex
- W2607129810
- Cited by
- 9,849
- References
- 18
- Citations by year
- 2026: 417 · 2025: 846 · 2024: 1177 · 2023: 1391 · 2022: 1762 · 2021: 1894 · 2020: 1418 · 2019: 689 · 2018: 225 · 2017: 20
- FWCI
- 266.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81573022, 31530036)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- gene expression profiling, cancer gene expression, RNA sequencing data, TCGA, GTEx, differential expression analysis, dimensionality reduction, web-based analysis tool
- MeSH terms
- Humans, Neoplasm Proteins, Neoplasms, User-Computer Interface, Gene Expression Regulation, Neoplastic, Survival Analysis, Internet, Gene Expression Profiling, Data Mining, Multifactor Dimensionality Reduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.